Pulmonx Corporation
LUNG
$4.52
-$0.27-5.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 6.85% | 7.71% | -11.47% | 1.00% | 6.79% |
| Total Depreciation and Amortization | 169.34% | -135.33% | 183.69% | 47.39% | -30.84% |
| Total Amortization of Deferred Charges | -98.64% | -12.89% | 5,718.75% | 23.08% | 0.00% |
| Total Other Non-Cash Items | -5.96% | -6.92% | -0.50% | 10.48% | -19.02% |
| Change in Net Operating Assets | -4.36% | -37.12% | 128.34% | -996.92% | 58.67% |
| Cash from Operations | 7.07% | -25.51% | 51.08% | -39.60% | 2.05% |
| Capital Expenditure | 73.32% | 11.30% | -3.99% | -125.50% | 59.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 97.82% | 2,058.20% | 82.20% | 19.53% | -272.75% |
| Cash from Investing | 108.37% | 908.50% | 66.69% | 9.00% | -379.13% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | -75.82% | 1,812.50% | -97.22% | 1,250.00% | -88.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -86.49% | 2,186.36% | -102.55% | 4,982.35% | -97.02% |
| Foreign Exchange rate Adjustments | 262.18% | -158.70% | -195.83% | 122.86% | -203.96% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,127.81% | 97.74% | 50.16% | -17.49% | -65.99% |